Skip to main content
. 2011 Dec 26;2011:890758. doi: 10.1155/2011/890758

Table 3.

Ongoing treatment studies evaluating EGFR MoAbs in cervical cancer patients.

Protocol number Disease stage Target therapy Adjuvant treatment Study phase PI
NCT00803062 Stage IVb/ Bevacizumab Cisplatin/topotecan hydrochloride/paclitaxel Phase III Krishnansu Tewari, MD
recurrent/persistent
NCT00548418 Recurrent/Persistent Bevacizumab Topotecan/cisplatin Phase II Janet S Rader, MD